Beyond its valuable contribution to society, healthcare is also a major economic sector that places considerable pressure on the environment. This also means it must take an active part in the transition towards more environmental sustainability, especially as the demand for healthcare will continue to increase in the future. If nothing is done to actively mitigate the sector’s impact on the environment, this impact will inevitably increase as a result.
The environmental impact of healthcare is a relatively recent and rapidly evolving research field. When selecting indicators, we therefore had to take into account not only their relevance but also the availability of data. This explains why certain aspects, like the insulation of buildings, could not be investigated.
The 17 indicators chosen to assess the impact of the Belgian healthcare system on the environment cover seven main topics:
- The overall environmental footprint of the healthcare system, assessed through direct and indirect greenhouse gas emissions (ENV-1), the material footprint (ENV-2) and the land use footprint (ENV-3)
- Air emissions, and more specifically direct emissions of greenhouse gases (ENV-4) fine particulate matter (ENV-5), acidifying gases (ENV-6) and ozone precursors (ENV-7)
- Building and energy management, assessed through fossil energy consumption (ENV-8) and the percentage of hospitals that have conducted an energy audit (ENV-9)
- The carbon footprint of medical products, namely reliever and preventer inhalers (ENV-10a and ENV-10b), anaesthetic gases (ENV-11) and nitrous oxide (N₂O) (ENV-12)
- Sustainable food, assessed through food waste from healthcare facilities (ENV-13)
- Waste management and circular economy, assessed through the volume of primary waste produced (ENV-14) and the percentage of hospitals with a designated person responsible for implementing a strategy on waste recycling, waste reduction, or circular economy (ENV-15)
- Water management, assessed through indicators on water consumption (ENV-16) and on the hazard potential of pharmaceuticals in surface water (ENV-17).
IMA-AIM = interMutualistisch agentschap-agence intermutualiste, NPB = National planning bureau, NHS = National Health Service, OVAM = Openbare Vlaamse Afvalstoffenmaatschappij, VIPA = Vlaams Infrastructuurfonds voor Persoonsgebonden Aangelegenheden, VITO = Vlaamse Instelling voor Technologisch Onderzoek, 1 Talbot A, Hollander HC, Bentzer P. Greenhouse gas impact from medical emissions of halogenated anaesthetic agents: a sales-based estimate. Lancet Planet Health. 2025;9(3):e227-e35.
! = Score to be used with caution because of methodological weaknesses, NR = Comparison not reliable due to differences in methods.
Overall environmental footprint of the healthcare system
The environmental impact of healthcare involves factors such as energy consumption, infrastructure and the use of a wide range of goods and services. To assess this comprehensively, we have selected three broad and interrelated indicators relating to greenhouse gas emissions (ENV-1), resource extraction (ENV-2) and land use (ENV-3).
These indicators cover not only the direct impact of healthcare at the point of delivery, but also the indirect impact arising from upstream activities. This clarification is important, as a large proportion of the total impact is indirect. It also reminds us that the healthcare sector does not operate in isolation and that the transition towards greater environmental sustainability will require a comprehensive effort, transcending sectors and borders.
It is also important to note that the results for this section are not measured directly but estimated using an economic analysis model that links healthcare expenditure to environmental impact. These estimates are relatively rough and may vary depending on the model’s parameters and assumptions, as well as on the data sources used.
Total direct and indirect greenhouse gas emissions (scope 1, 2 and 3) of the healthcare sector (ENV-1)
This indicator concerns the total greenhouse gas (GHG) emissions of the healthcare sector, which fall into three categories: emissions directly linked to the operation of healthcare facilities (scope 1, see also indicator ENV-4), those resulting from the consumption of purchased energy (scope 2) and those arising from activities that are necessary to allow the sector to operate, e.g. for the production of medical or food products or for waste treatment (scope 3).
The main GHGs associated with human activities are carbon dioxide (CO2), methane (CH4) and nitrous oxide (N2O).
- In 2022, depending on the source, direct and indirect GHG emissions from the healthcare sector ranged from 7 321 to 9 901 kilotons of CO2 equivalents, or 629 to 851 kg of CO2 equivalents per capita. Per capita emissions appear to have fallen slightly in our country between 2012 and 2022, reaching their lowest level in 2022.
- The healthcare sector’s GHG emissions account for approximately 5% of GHG emissions in Belgium. Excluding the COVID period, this share has remained relatively stable between 2012 and 2022 (between 4.9% and 5.5%).
- Over 80% of the healthcare sector’s GHG emissions are indirect scope 3 emissions, more than half of which are linked to medical products, particularly medicines. Direct emissions (scope 1) account for 11% of the total. Hospitals generate the bulk of the sector’s emissions (55% vs 22% for outpatient care).
- Based on 2018 data, per capita emissions in Belgium remain among the highest in Europe (731 kg CO2 eq/capita vs 560 kg on average for EU-14 countries and 450 kg for EU-27 countries). Only Germany performs worse. As a percentage of total emissions, our country ranks 4th with 5.5%, whilst the European averages are 4.9% (EU-14) and 4.3% (EU-27). An update based on 2022 figures is expected by the end of the year.
Link to the technical sheet and detailed results
Material environmental footprint of the healthcare sector (ENV-2)
The term ‘material footprint’ refers to the extraction of raw materials (biomass, fossil fuels, metallic and non-metallic minerals) to meet demand within the healthcare sector, ranging from energy and infrastructure to equipment, medicines, transport and food.
- In Belgium, the material footprint of the healthcare system amounts to approximately 1 000 kg per capita. This figure has remained broadly stable between 2012 and 2022 despite an increase in provided care, albeit with fluctuations depending on contextual factors (economic trends, COVID-19). The healthcare sector’s share of our country’s total material footprint also remains broadly stable (5.6–6.4% between 2012 and 2022, peaking at 6.7% during the pandemic).
- Non-metallic minerals, which feature heavily in infrastructure, account for more than half of the total. These are followed by biomass (mainly food, but also paper, textiles, construction timber, etc.) and fossil fuels (e.g. energy, transport, pharmaceuticals and chemicals, and plastics), each accounting for around 20%. At the same time, around three-quarters of the footprint relates to mining, with 20% attributable to agriculture and forestry.
- A very large proportion of the sector’s material footprint is generated by ‘supporting’ products and services (infrastructure, transport, catering, etc.) rather than by healthcare and health products in the strict sense. More than half of the raw materials required for the Belgian healthcare system to function come from countries outside the EU. Only 22% come from Belgium.
- The available international data is too old (2015) to allow for a meaningful comparison.
Link to the technical sheet and detailed results
Land use environmental footprint of the healthcare sector (ENV-3)
This indicator reflects the land use required to meet the needs of the healthcare sector. It covers direct land use (the space occupied by healthcare facilities) and land required for biomass production.
- In Belgium, the land use footprint of the healthcare sector has fallen slightly (5 587 km2 or 0.48 m2 per capita in 2022 vs 6 007 km2 or 0.54 m2 per capita in 2012). The sector’s share in our country’s total land use footprint remained broadly stable between 2012 and 2022, with figures ranging from 4.9% to 5.8%.
- The footprint stems mainly from current expenditure, driven primarily by the consumption of food and other biomass-based goods (e.g. paper, cardboard, wood, textiles), accounting for 20-25% of the total footprint each. More than two-thirds of the footprint is generated outside the EU, compared with just 7% in Belgium.
- The international data is too old (2015) to allow for a meaningful comparison.
Link to the technical sheet and detailed results
Air emissions
The indicators in this section cover four types of direct air emissions that have an impact on the environment: greenhouse gases (scope 1 only) (ENV-4), fine particulate matter (PM2.5) (ENV-5), acidifying gases (ENV-6) and ozone precursors (ENV-7).
Again, results for the indicators in this section are not measured directly but estimated through models from the Belgian National Planning Bureau. Furthermore, recent changes in methodology and certain specificities of the data collection have had an impact on the international comparison. The results for these four indicators must therefore be interpreted with extreme caution.
In particular, the international comparison is unreliable due to methodological differences between countries, and we have therefore chosen not to detail it below. Belgium’s performance appears poor for these four indicators, suggesting that further efforts are needed, but this will require confirmation from higher-quality data.
Wallonia also seems to lag behind the other regions on all the indicators in this section. Further analysis would be required to clarify the reasons behind this finding, but factors such as greater distances or the more frequent use of oil heating systems could play a role.
Direct greenhouse gas emissions (scope 1) of the healthcare sector (ENV-4)
This indicator concerns the direct GHG emissions of the healthcare sector, namely those resulting from the combustion of fossil fuels (e.g. heating oil) in healthcare facilities and the operation of the vehicle fleet. Carbon dioxide (CO2) accounted for nearly 97% of the GHG emissions of the Belgian healthcare sector in 2023.
- In Belgium, the annual GHG emissions of the healthcare sector amounted to nearly 1.3 million tonnes of CO2 equivalents (CO2 eq) in 2023, a 71% increase since 2012 based on the new methodology introduced in 2023. It should be noted, however, that based on the old methodology, the GHG emissions of the healthcare sector have barely increased between 2012 and 2022 (+0.2%). We have therefore chosen not to indicate a trend.
- The differences between regions are striking: whilst figures are similar in Flanders (81 kg CO2 eq/capita) and Brussels (76 kg), figures for Wallonia are almost twice as high (154 kg) (based on the data for 2022). Methodological factors certainly play a part, but are unlikely to entirely account for a difference of this magnitude.
Link to the technical sheet and detailed results
Particulate matter (PM2.5) emissions of the healthcare sector (ENV-5)
PM2.5 are harmful small particles found in the air, which can cause serious health problems such as cancer or heart and respiratory diseases. They are thought to cause 5 million deaths worldwide every year.
- In 2023, the Belgian healthcare sector generated 94 tonnes of PM2.5 (8 g per capita), 18% more than in 2012. However, this represents only 0.5% of national PM2.5 emissions.
- As with GHGs, Flanders (4.5 g/capita in 2022) and Brussels (4.6 g) are neck and neck, whilst Wallonia is close to 13 g/capita.
Link to the technical sheet and detailed results
Acidifying gas emissions of the healthcare sector (ENV-6)
Acidifying gases are air pollutants that can have a negative impact on plant growth, on animal life and on the quality of soil and groundwater.
The main acidifying gases are sulphur dioxide (SO₂), nitrogen oxides (NOx) and ammonia (NH₃); the emissions of the Belgian healthcare sector comprise mostly nitrogen oxides.
- The Belgian healthcare system’s emissions of acidifying gases have remained stable over time, rising from 109 g of SO2 equivalents per capita (g SO2 eq/capita) in 2012 to 111 g in 2023 (+1.4%).
- Emissions are, again, significantly higher in Wallonia (184 g SO2 eq/capita in 2022, vs 73 g in Flanders and 63 g in Brussels).
Link to the technical sheet and detailed results
Ozone precursor emissions of the healthcare sector (ENV-7)
Ozone (O3) in the lower layers of the atmosphere can lead to harmful smog, that is particularly detrimental for people with respiratory conditions.
This indicator concerns ozone precursors, i.e. substances which, when released into the air, cause ozone to form through chemical reactions of varying speeds. This group includes non-methane volatile organic compounds (NMVOCs), nitrogen oxides (NOx), carbon monoxide (CO) and methane (CH4). The majority of the Belgian healthcare sector’s emissions relate to nitrogen oxides (78% in 2023).
- In 2023, the Belgian healthcare sector’s emissions amounted to 224 g NMVOC equivalents per capita (or just over 2 600 tonnes). This is only a small fraction (1%) of total ozone precursor emissions in our country, but this share has almost doubled since 2012.
- Once again, emissions of ozone precursors are twice as high in Wallonia (350 g NMVOC eq/capita) as in Flanders (156 g) and Brussels (124 g) (2022 figures).
Link to the technical sheet and detailed results
Building and energy management
Two indicators have been selected for this topic: consumption of energy from fossil sources (ENV-8) and the proportion of general hospitals that have conducted an energy audit or scan since 2018 (ENV-9). Hospitals and other healthcare facilities are highly energy-intensive buildings, whose reliance on fossil fuels contributes significantly to the sector’s environmental footprint. Assessing this consumption (and its trends) and the energy performance of buildings is important to help us move towards greater environmental sustainability.
The results for fossil fuel consumption were estimated using a model developed by the National Planning Bureau. Differences between countries make international comparisons unreliable.
A sub-indicator of ENV-1 (total direct and indirect GHG emissions) relates to GHG emissions from buildings and energy consumption. These account for just under 15% of the healthcare sector’s direct and indirect GHG emissions.
Fossil fuel consumption in the healthcare sector (ENV-8)
In the Belgian healthcare sector, fossil fuels are used mainly for transport and heating. The most commonly used energy sources in this context in our country are natural gas, diesel and, to a lesser extent, petrol.
- In 2022, the Belgian healthcare sector consumed a total of 16 428 terajoules of fossil fuels, or 1.4 gigajoules (GJ) per capita. This comes down to 76% of the healthcare sector’s total energy consumption and 0.7% of Belgium’s total fossil fuel consumption (excluding fuel used in transport) across all sectors. Fossil fuel consumption in the healthcare sector is increasing in our country, both in absolute terms and per capita.
- Per capita fossil fuel consumption in the healthcare sector is higher in Wallonia (2 GJ/capita) than in Brussels and Flanders (around 1 GJ/capita in both cases). Based on another data source that focuses specifically on hospitals (based on expenditure rather than consumption), Wallonia is closer to Flanders but shows higher consumption of heating oil.
Link to the technical sheet and detailed results
Proportion of general hospitals that have carried out an energy audit since 2018 (ENV-9)
Between 2018 and 2025, the Flemish Infrastructure Fund (VIPA) offered free energy audits carried out by experts, with the aim of identifying measures to reduce energy consumption and facilitate the production of renewable energy, thereby contributing to the carbon neutrality targets for 2045-2050.
- Between 2018 and 2025, 52 out of 59 general hospitals (88%) underwent an energy audit.
- General hospitals, along with psychiatric hospitals, were the healthcare facilities that most frequently benefited from an audit and grants for energy-saving measures. This was a positive finding given that the greatest potential of healthcare-related reduction of emissions was with hospitals, as they were responsible for approximately 55% of the emissions of the full healthcare sector.
- The measures most frequently recommended in general hospitals were lighting upgrades (replacement of light bulbs/fluorescent tubes or upgrading of the entire system) and the installation of photovoltaic solar panels. These two measures ranked first and third, respectively, on the list of the most subsidised measures.
Link to the technical sheet and detailed results
Medical products with a high carbon footprint
Emissions linked to medical products – particularly medicines – account for a significant proportion of direct and indirect GHG emissions from the healthcare sector in Belgium (see also ENV-1). However, certain substances are particularly harmful to the environment. This is the case for the gases used in metered-dose inhalers for certain respiratory conditions (which account for 0.4% of total emissions), as well as for certain anaesthetic gases.
This section covers three indicators relating to the use of low-carbon-footprint inhalers (ENV-10a and ENV-10b), the GHG impact of anaesthetic gases (ENV-11) and direct emissions of nitrous oxide (ENV-12).
Prescription of low-carbon-footprint reliever (SABA) and preventer (ICS-LABA) inhalers (ENV-10a and ENV-10b)
Inhalers are used to treat respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD), either as rescue treatment to provide rapid symptom relief (short-acting bronchodilators, SABA) or as maintenance treatment (long-acting beta-agonists, LABA).
Metered-dose inhalers (MDIs) use pressurised canisters that release the medication through the action of a greenhouse gas. Other devices, such as dry powder inhalers and nebuliser inhalers, are less harmful to the environment and should be preferred.
- The use of low-carbon reliever inhalers is declining in our country: in 2023, they accounted for only 45% of reliever inhalers, whereas this share exceeded 75% in 2012. However, this could be partly explained by the fact that these ‘rescue’ devices are increasingly targeted at the most severe cases (their overall use has, in fact, been reduced by half), for which alternatives that are both more environmentally friendly and sufficiently effective are not always available.
- As for preventer inhalers (LABAs), the share of low-carbon devices remains high (77% in 2023) and has been very stable since 2012. The total number of prescriptions has also decreased (-7.2%).
- Furthermore, the share of low-carbon inhalers varies by age group. For reliever inhalers, it is higher among patients under 12 (68% in 2023) than among those aged 12–64 (18%) and those aged 65 and over (37%). For preventer inhalers, the opposite is true, with 56% of low carbon footprint-devices in the youngest age group, 81% in teenagers and adults, and 78% in older adults. The trend over time broadly follows the overall pattern.
- What little international data is available suggests that Belgian results for this indicator are fairly good. The warning signal regarding the prescription of SABA inhalers is not linked to prescribers’ behaviour, but to the fact that there is often no suitable low-carbon alternative. It is therefore primarily directed at the pharmaceutical industry.
Link to the technical sheet and detailed results
GHG impact of anaesthetic gases (ENV-11)
Anaesthetic gases account for around 3% of the healthcare sector’s carbon footprint and have a significant impact on global warming. Intravenous products should be used as a substitute whenever possible.
When anaesthetic gases are absolutely necessary, it is advisable to prioritise products (such as sevoflurane) and techniques (low-flow anaesthesia) with a lower climate impact. Desflurane, which is particularly harmful, should be phased out completely. Since early 2026, its use in the EU has, in fact, been subject to stringent restrictions.
- In Belgium, the use of desflurane fell by almost half between 2015 and 2024 (based on reimbursement data). Sevoflurane is by far the most widely used anaesthetic gas in the Belgian healthcare system (around 25 000 litres per year vs less than 1000 litres for desflurane), and its consumption increased by nearly 6% between 2015 and 2024.
- Nonetheless, there is still significant room for improvement in our country, particularly when comparing Belgian results with those of other European countries: in 2023, the GHG impact of anaesthetic gases used in Belgium (1.8 kg CO2 eq/capita) was twice as high as the European average (0.9 kg, based on 25 countries).
Link to the technical sheet and detailed results
Direct emissions of nitrous oxide (N₂O) from the healthcare sector (ENV-12)
Nitrous oxide, also known as laughing gas, is an anaesthetic and analgesic gas that has long been used in medicine. Its carbon footprint, which is 120 times greater than that of CO2 , makes it one of the most significant greenhouse gases after CO2 and methane. It is also the gas with the greatest impact on the ozone layer. In Belgian hospitals, it is now used mainly in children.
- N2O emissions from the Belgian healthcare system stood at 94 tonnes in 2024, compared with 254 tonnes in 2013 (-63%). This trend could be explained by the phasing out of a centralised distribution system which came with significant leaks (70-90%), as the number of minutes of use per year has, in fact, increased (+31% between 2015 and 2023). The healthcare system accounts for less than 2% of N2O emissions in Belgium, which are mainly attributable to the agricultural sector.
- The Belgian results are in line with European averages, but the lack of data on the proportion of hospitals using the new distribution method (which releases less gas and is therefore less harmful in terms of emissions) prevents us from rating this indicator.
Link to the technical sheet and detailed results
Sustainable food
It may not be the first thing that comes to mind when talking about the environmental sustainability of the healthcare sector, but facilities such as hospitals, nursing homes and other residential settings also have to organise meals for their patients or residents, staff and visitors. The production, processing and preparation of food are likely to have a significant environmental impact, as is the subsequent management of the resulting waste.
This section currently contains one single indicator, which relates to the volume of food waste in residential care (ENV-13).
However, a sub-indicator of ENV-1 (direct and indirect GHG emissions) addresses GHG emissions linked to these catering activities, which account for just under 8% of the sector’s total emissions. Indicator ENV-3 (land use) also includes data broken down by type of activity; catering activities are responsible for 20-25% of the total land use of the healthcare sector.
Annual volume of food waste in hospitals and residential care facilities (ENV-13)
Since 2022, the Flemish waste agency (OVAM) has had a data monitoring system fed by waste collection and treatment operators (on a mandatory basis), which provides it with statistics for the Flemish Region. An equivalent system is not yet available for the other Belgian regions, and data for this indicator is therefore available for Flanders only. It is also too early to assess a trend.
- In 2024, Flemish care facilities generated just over 10 kilotonnes of food waste (1.5 kg/capita), of which just over half came from nursing homes and around a third from general hospitals. These figures likely underestimate reality, as part of the food waste may have ended up in other waste streams.
- Available data suggests that a relatively small proportion of this waste ends up in landfills, but do not allow us to establish with certainty how it is processed.
Link to the technical sheet and detailed results
Waste management and circular economy
Two indicators have been selected for this theme: one on the annual volume of primary waste in the healthcare sector (ENV-14) and one on the proportion of hospitals where a specific person is in charge of implementing a recycling, waste reduction or circular economy strategy (ENV-15). Data for this second indicator are not yet available, but should be by the time the next comprehensive health system performance assessment report is published.
Annual volume of primary waste in the healthcare sector (ENV-14)
‘Primary waste’ refers to waste generated by human activities other than waste treatment (extraction of raw materials, production chain, use/consumption, cleaning, etc.), i.e. waste generated at source and which has not yet been treated. Like ENV-13, this indicator is based on data collected since 2022 by the Flemish waste agency (OVAM).
- In 2024, the healthcare sector in the Flemish Region generated a total of 106 kilotonnes of waste, or just under 16 kg per capita. The largest producer of waste was the sector of nursing homes (42%), closely followed by general hospitals (38%). However, when calculated per bed, hospitals produced just under 5 kg/bed/day, compared with just over 1 kg/bed/day for nursing homes.
- Residual waste accounted for 33% of the sector’s total, with non-hazardous medical waste making up 17%. In general hospitals, medical waste made up the largest category (40%), whilst nursing homes mainly generated residual waste (63%).
- Medical waste (whether hazardous or non-hazardous) was almost always incinerated (97%); alternatives to incineration could be considered for non-hazardous medical waste. The way most residual waste is currently processed is not clearly established.
Link to the technical sheet and detailed results
Water management
Water is a valuable and often indispensable resource. Hospitals and residential care facilities consume significant amounts of it for cleaning and sterilisation activities, as well as for their cooling systems. The healthcare system is also a source of surface water pollution, because conventional wastewater treatment plants are not always able to remove drug residues excreted by the body or washed away (e.g. creams). These can have negative effects on the environment, be present in small quantities in drinking water and contribute to antibiotic resistance.
This section includes two indicators: one relating to water consumption in the healthcare sector (ENV-16), and the other to the risk of pollution from pharmaceutical residues (ENV-17), assessed on the basis of the consumption of reimbursed medicines, for which data is expected by mid-2026.
Annual water consumption in the healthcare sector (ENV-16)
- In Flanders, water consumption in the healthcare sector has remained fairly stable over time, rising from 0.59 m3 per capita in 2012 to 0.68 m3 per capita in 20221 . Over 90% of this consumption relates to tap water.
- The healthcare system accounts for 1.40% of total water consumption in the Flemish Region, and 57% of the sector’s consumption relates to hospitals, which use 171 m3 per bed per year.
- International data is too outdated to allow for a meaningful comparison. Nevertheless, the fact that water consumption in the sector seems to be slightly increasing, is at odds with the European Commission’s ambition to reduce water consumption and increase water efficiency by 10% across the EU.
---
- Excluding cooling water, which accounts for a significant volume but relates to only one hospital. The relevant figures are available in the indicator’s technical data sheet.



